New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
16:15 EDTTHRXTheravance initiates Phase 2 study with TD-9855 for treatment of fibromyalgia
announced today initiation of a fibromyalgia Phase 2 study with TD-9855. TD-9855 is an investigational norepinephrine and serotonin reuptake inhibitor for the treatment of central nervous system conditions such as chronic pain and Attention-Deficit/Hyperactivity Disorder.
News For THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
05:25 EDTTHRXTheravance announces positive Anoro Ellipta study data published
Subscribe for More Information
October 9, 2014
16:09 EDTTHRXTheravance names Eric d'Esparbes as CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use